Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs SANOFI INDIA - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC SANOFI INDIA ALEMBIC/
SANOFI INDIA
 
P/E (TTM) x 59.1 42.5 139.0% View Chart
P/BV x 5.1 8.7 58.9% View Chart
Dividend Yield % 0.2 1.0 19.9%  

Financials

 ALEMBIC   SANOFI INDIA
EQUITY SHARE DATA
    ALEMBIC
Mar-18
SANOFI INDIA
Dec-18
ALEMBIC/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs726,840 1.1%   
Low Rs344,630 0.7%   
Sales per share (Unadj.) Rs4.71,203.1 0.4%  
Earnings per share (Unadj.) Rs6.1165.3 3.7%  
Cash flow per share (Unadj.) Rs6.2209.9 3.0%  
Dividends per share (Unadj.) Rs0.2084.00 0.2%  
Dividend yield (eoy) %0.41.5 25.8%  
Book value per share (Unadj.) Rs40.7963.6 4.2%  
Shares outstanding (eoy) m267.0323.03 1,159.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.8 236.3%   
Avg P/E ratio x8.734.7 25.0%  
P/CF ratio (eoy) x8.527.3 31.0%  
Price / Book Value ratio x1.36.0 21.9%  
Dividend payout %3.350.8 6.4%   
Avg Mkt Cap Rs m14,139132,078 10.7%   
No. of employees `000NA3.3 0.0%   
Total wages/salary Rs m2074,068 5.1%   
Avg. sales/employee Rs ThNM8,393.8-  
Avg. wages/employee Rs ThNM1,232.4-  
Avg. net profit/employee Rs ThNM1,153.0-  
INCOME DATA
Net Sales Rs m1,25527,708 4.5%  
Other income Rs m370897 41.3%   
Total revenues Rs m1,62528,605 5.7%   
Gross profit Rs m1116,235 1.8%  
Depreciation Rs m381,027 3.7%   
Interest Rs m27 24.3%   
Profit before tax Rs m4426,098 7.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m242,292 1.0%   
Profit after tax Rs m1,6303,806 42.8%  
Gross profit margin %8.922.5 39.3%  
Effective tax rate %5.437.6 14.4%   
Net profit margin %129.813.7 945.3%  
BALANCE SHEET DATA
Current assets Rs m1,86715,922 11.7%   
Current liabilities Rs m5916,235 9.5%   
Net working cap to sales %101.635.0 290.7%  
Current ratio x3.22.6 123.7%  
Inventory Days Days9464 148.1%  
Debtors Days Days7421 352.4%  
Net fixed assets Rs m1,7917,539 23.8%   
Share capital Rs m534230 232.2%   
"Free" reserves Rs m10,32421,962 47.0%   
Net worth Rs m10,85822,192 48.9%   
Long term debt Rs m410-   
Total assets Rs m11,59129,839 38.8%  
Interest coverage x260.9872.1 29.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.10.9 11.7%   
Return on assets %14.112.8 110.2%  
Return on equity %15.017.2 87.5%  
Return on capital %15.227.5 55.2%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m197,587 0.3%   
Fx outflow Rs m2647,145 3.7%   
Net fx Rs m-244442 -55.3%   
CASH FLOW
From Operations Rs m2363,739 6.3%  
From Investments Rs m-224-731 30.6%  
From Financial Activity Rs m-27-1,972 1.3%  
Net Cashflow Rs m-151,036 -1.4%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 0.2 14.4 1.4%  
FIIs % 9.7 14.6 66.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 10.5 248.6%  
Shareholders   54,701 15,184 360.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   STERLING BIOTECH  NOVARTIS  ALEMBIC PHARMA  ORCHID PHARMA  PFIZER  

Compare ALEMBIC With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 470 Points Lower; Tata Motors & Tata Steel Fall 6%(Closing)

Indian share markets witnessed huge selling pressure today, in line with global equities and fell on to bearish territory.

Related Views on News

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Jan 18, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS